Key result
Elevated cardiac troponin levels were an independent predictor of 30-day mortality in hospitalized COVID-19 patients (adjusted OR 3.00).
Why the study?
Myocardial injury is common and linked to severity in COVID-19, but its prevalence, prognostic utility, and the separate roles of troponin T and I required analysis in a large population.
Does elevated cardiac troponin predict 30-day mortality in hospitalized COVID-19 patients?
Observational (n=1,280)
Yes
Does elevated cardiac troponin predict 30-day mortality in hospitalized COVID-19 patients?
Effect estimate: OR 3.00
Elevated cardiac troponin is a common finding and an independent predictor of 30-day mortality in hospitalized COVID-19 patients, supporting its use for early risk stratification.
No takes yet. Share an insight, caveat, or question.
May support troponin for risk stratification in hospitalized COVID-19; leaves open need for prospective validation.
Guadiana‐Romualdo et al. (2021) conducted an observational in COVID-19 (n=1,280). Elevated cardiac troponin vs. Normal troponin levels was evaluated on 30-day mortality (OR 3.00). Elevated cardiac troponin levels were an independent predictor of 30-day mortality in hospitalized COVID-19 patients (adjusted OR 3.00).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: